Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434979 · ClinicalTrials.gov registry record
Exertional Heat Illness: Biomarkers for Prediction and Return to Duty
A clinical trial of Heat Illness, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- 148
- Enrollment target
- 2
- Study locations
NCT01434979: Completed study of Heat Illness, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
NCT01434979 is a study of Heat Illness that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 148 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01434979, a study of Heat Illness, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators goal is to monitor and quantify the differential physiologic and biomarker responses of controls to standardized exercise under thermoneutral and thermally challenged conditions and responses of exertional heat stroke (EHS) subjects under a thermal-challenged environment to develop unique bio-signature panels to predict those at risk for exertional heat illness (EHI) and guide return to duty following an episode of EHS.
Primary Outcome
Heat tolerance is determined by physiologic response to a 2-hour heat tolerance test. During this test, participants with core temperature greater than 38.5 C and/or heart rate greater than 150 bpm are considered heat intolerant.
Conditions Studied
Study Locations (2)
Maryland
- Uniformed Services University of the Health Sciences - Bethesda
Other
- Heller Institute of Medical Research - Tel Litwinsky
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2011-07 |
| Est. Completion | 2016-02 |
What the finished NCT01434979 record still lists
NCT01434979 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Heat Illness appearing as the primary indexed condition, and to 0 interventions.
NCT01434979 reports a single indexed study location in Maryland, Other.
Frequently Asked Questions
What is clinical trial NCT01434979 about?
NCT01434979 is a clinical study titled "Exertional Heat Illness: Biomarkers for Prediction and Return to Duty". The investigators goal is to monitor and quantify the differential physiologic and biomarker responses of controls to standardized exercise under thermoneutral and thermally challenged conditions and responses of exertional heat stroke (EHS) subjects under a thermal-challenged environment to develop...
What is the current status of trial NCT01434979?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2011-07. Estimated completion is 2016-02.
What conditions does trial NCT01434979 study?
This clinical trial studies the following conditions: Heat Illness.
Who is sponsoring clinical trial NCT01434979?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01434979 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia